Tags

Type your tag names separated by a space and hit enter

Melioidosis; the remarkable imitator: recent perspectives.
J Assoc Physicians India. 2004 May; 52:417-20.JA

Abstract

Melioidosis is an important public health problem in some regions of the world. It is endemic in South East Asia. The clinical spectrum of melioidosis is extremely broad, and melioidosis requires awareness on the part of the clinician and the existence of a laboratory capable of isolating and identifying Burkholderia pseudomallei, the etiological agent of melioidosis. Beta-lactams such as ceftazidime is currently the treatment of choice. There is no vaccine licensed for human use. There is an urgent need for rapid diagnostic techniques and effective treatments that are affordable in countries where the disease is endemic.

Authors+Show Affiliations

Department of Microbiology, All India Institute of Medical Sciences, New Delhi.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15656034

Citation

Loveleena, , et al. "Melioidosis; the Remarkable Imitator: Recent Perspectives." The Journal of the Association of Physicians of India, vol. 52, 2004, pp. 417-20.
Loveleena , Chaudhry R, Dhawan B. Melioidosis; the remarkable imitator: recent perspectives. J Assoc Physicians India. 2004;52:417-20.
Loveleena, ., Chaudhry, R., & Dhawan, B. (2004). Melioidosis; the remarkable imitator: recent perspectives. The Journal of the Association of Physicians of India, 52, 417-20.
Loveleena , Chaudhry R, Dhawan B. Melioidosis; the Remarkable Imitator: Recent Perspectives. J Assoc Physicians India. 2004;52:417-20. PubMed PMID: 15656034.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Melioidosis; the remarkable imitator: recent perspectives. AU - Loveleena,, AU - Chaudhry,Rama, AU - Dhawan,Benu, PY - 2005/1/20/pubmed PY - 2005/3/2/medline PY - 2005/1/20/entrez SP - 417 EP - 20 JF - The Journal of the Association of Physicians of India JO - J Assoc Physicians India VL - 52 N2 - Melioidosis is an important public health problem in some regions of the world. It is endemic in South East Asia. The clinical spectrum of melioidosis is extremely broad, and melioidosis requires awareness on the part of the clinician and the existence of a laboratory capable of isolating and identifying Burkholderia pseudomallei, the etiological agent of melioidosis. Beta-lactams such as ceftazidime is currently the treatment of choice. There is no vaccine licensed for human use. There is an urgent need for rapid diagnostic techniques and effective treatments that are affordable in countries where the disease is endemic. SN - 0004-5772 UR - https://www.unboundmedicine.com/medline/citation/15656034/Melioidosis DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.